TOL2708C
Drug
TOLMAR, INC.
Total Payments
$111,095
Transactions
18
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $111,095 | 18 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $111,095 | 18 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TOL2708C | TOLMAR, INC. | $111,095 | 0 |
Top Doctors Receiving Payments for TOL2708C
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | El Paso, TX | $111,095 | 18 |
Ad
Manufacturing Companies
- TOLMAR, INC. $111,095
Product Information
- Type Drug
- Total Payments $111,095
- Total Doctors 0
- Transactions 18
About TOL2708C
TOL2708C is a drug associated with $111,095 in payments to 0 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is TOLMAR, INC..
Payment data is available from 2018 to 2018. In 2018, $111,095 was paid across 18 transactions to 0 doctors.
The most common payment nature for TOL2708C is "Unspecified" ($111,095, 100.0% of total).
TOL2708C is associated with 1 research study, including "TOL2708C" ($111,095).